ERAPHAR
ActiveSummary
ERAPHAR has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €39,157 and a net result of €12,094. Equity is growing by about 41% per year across the filed financial years. Its solvency ranks better than 86% of 22,080 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
25-08
NBB filing
Annual accounts filed
financial year 2025 · micro format · 25 days late
2025
19-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 19 days late
2024
31-12
Financial
Weakest financial yearnet €10,209 ▼38.7%
Net result drops to €10,209, the lowest in the series; recovery starts the following year.
13-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 13 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.